All Stories

  1. Advantages of myeloid progenitors over of macrophages or neutrophils for myeloid cell therapies.

    Article • npj Regenerative Medicine, December 2023, Springer Science + Business Media

    Dr. med. Willem Buys

  2. Early sepsis is very heterogeneous but proper patient selection might still allow effective therapy

    Article • Frontiers in Immunology, October 2023, Frontiers

    Dr. med. Willem Buys

  3. Double-edged immunity in early sepsis: Too much and too little inflammation at the same time.

    Article • PLoS ONE, August 2022, PLOS

    Dr. med. Willem Buys